Cellares CEO discusses its recent fund raise and Cell Shuttle impact in cell therapy manufacturing
Fabian Gerlinghaus, CEO of Cellares, discusses the company's recent $255M Series C funding, the impact of their Cell Shuttle in cell therapy manufacturing, and the growth of strategic partnerships on #NYSEFloorTalk with Judy Khan Shaw.
▶︎
$PATH PANIC | Addressing UiPath Stock FUD + 8 Reasons Why It REMAINS Uniquely Positioned To DOMINATE
▶︎
Cellares
▶︎
CHOSEN ONE!! THEY'RE BEGGING HIM TO WARN YOU... BUT HE JUST GRINNED AND SAID "TOO LATE"
▶︎
🚨La FIFA intentó HUMILLAR a México…😭 pero el mundo entero se puso LA VERDE
▶︎
Infleqtion Stock (INFQ): The Only Real Quantum Business. So Why Are Insiders Selling?
▶︎
My Golden Retriever Heals a Terrified Rescue Kitten in Just 3 Meetings!
▶︎
Mr Beans Zahnarztprobleme | Mr Bean Deutschland
▶︎
Timelapse - Catching Fresh Fish & Cooking Over Campfire | Solo Bushcraft
▶︎
Midnight in Beirut 🌙 | Lebanese Jazz & Oud Melodies for Relaxation & Deep Focus
▶︎
When Animals Surprise Photographers in the Sweetest Way! 😍
▶︎
We Relocated the Handwheel on Our MONSTER Lathe | Megabore Lathe Setup
▶︎
1986: How to Spot the Upper Class | That's Life! | BBC Archive
▶︎
Cellares in Global Health | Redefining Cell Therapy Manufacturing
▶︎
Perfect Couple's Explorer 🤯 Selene 54 Classic Explorer Liveaboard Long Range Yacht Tour
▶︎
7 Western Hygiene Habits That Disgust Japanese People
▶︎
The Most Hilarious Minions Short Films
▶︎
65 Year Old Carpenter's Genius Pallet Idea: Smart And Practical Interior Design
▶︎
20 Of The Most Beautiful Classical Adagios for Relaxation and Peace in Rachmaninoff Style
▶︎
Watch his reaction when he’s told he’s a GOOD BOY for the first time 🥹
▶︎